PharmSource-CMO Scorecard: Outsourcing of NDA Approvals and CMO Performance-2017 Edition

PharmSource-CMO Scorecard: Outsourcing of NDA Approvals and CMO Performance-2017 Edition


  • Products Id :- GDPS0016MAR
  • |
  • Pages: 42
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

PharmSource-CMO Scorecard: Outsourcing of NDA Approvals and CMO Performance-2017 Edition

Summary

Where's your place in the CMO hierarchy?

Find out in the CMO industry's authoritative analysis of manufacturing of NDA approvals. This CMO scorecard was compiled through hundreds of professional hours of research and analysis, and is presented in a 40-page report with over 30 graphs and tables. Only CMO Scorecard enables the CMO industry to benchmark its performance over time, and CMOs to benchmark their performance against the industry.

Our research team crunched the numbers on 2016 drug approvals authorized by FDA's CDER, CBER, Fast Track and Breakthrough drugs, and selected EMA approved drugs. For the first time, we are including information on the location of outsourced dose manufacturing facilities.

Reasons to buy

This report is required reading for -

CMO executives and strategic decision-makers who seriously follow the global CMO industry, including dose and API manufacturers.

Bio/Pharma sponsors that buy contract manufacturing services and need to understand contract manufacturing industry drivers.



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

1 Table of Contents

Executive Summary

Introduction

NDA Approvals Overview

US vs. EU Approval Performance

Outsourced Dose Manufacture

Special Product Categories

Outsourcing by Global Bio/Pharma Companies

Outsourced Dose Form

Manufacture by Country

CMO Performance

Outsourced API Approvals

What It Means

Note on Methodology

Appendix

1.2 List of Figures

Figure 1 NDA Approvals 2007-2016

Figure 2 NDA Approvals by Sponsor Type 2007-2016

Figure 3 EMA Approvals 2012-2016

Figure 4 Share of NDA Approvals Outsourced 2007-2016

Figure 5 Absolute Numbers of Outsourced NDA Approvals 2007-2016

Figure 6 Outsourcing of Small and Large Molecule API NMEs 2007-2016

Figure 7 Outsourcing of NME Approvals by Sponsor Type

Figure 8 Outsourcing of Non-NME NDA Approvals by Sponsor Type

Figure 9 Outsourcing of Orphan NMEs 2007-2016

Figure 10 Breakthrough NME Drug Approvals 2013-2016

Figure 11 Fast Track NME Drug Approvals 2001-2016

Figure 12 NMEs Requiring Special Handling 2007-2016

Figure 13 Approval and Outsourcing of Advanced Formulation Technologies 2011-2016

Figure 14 Global Bio/pharma Outsourcing Propensity 2007-2016

Figure 15 Manufacturing Location for Outsourced Non-NME NDA Dose Manufacturing 2007-16

Figure 16 Manufacturing Location for Outsourced NME Dose Manufacturing 2007-2016

Figure 17 Manufacturing Location for In-House NME Dose Manufacturing 2007-2016

Figure 18 Manufacturing Location for In-House Non-NME NDA Dose Manufacturing 2007-2016

Figure 19 CMO Market Share of Parenteral NME Approvals 2007-2016

Figure 20 CMO Market Share of Parenteral Non-NME NDA Approvals 2007-2016

Figure 21 CMO Market Share of Solid NME Approvals 2007-2016

Figure 22 CMO Market Share of Solid, Non-NME Approvals 2007-2016

Figure 23 Outsourced NME API Manufacture 2007-2016

1.1 List of Tables

Table 1 Approvals by Dosage Form

Table 2 Outsourced NDA Approvals by Dosage Form

Table 3 Outsourcing by Sponsor Type and FDA Approval Type 2011-2016

Table 4 Dose CMOs Receiving Approvals in 2016

Table 5 API CMOs Receiving NME Approvals in 2016

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to sales [@] kenresearch.com
 

select a license

Single User License
USD 2995 INR 217197
Site License
USD 5990 INR 434395
Corporate User License
USD 8985 INR 651592

NEWSLETTER BY CATEGORY




Testimonials

An excellent provider. Thorough, precise and outstanding insight. They drill down to what we need and their reports are effective at integrating text with supporting graphics and charts. Their reports are a great resource to go back too. ...

Coherent, high-quality, thoroughly-researched reports. We received a very quick response to all our queries which eventually expedited the entire process....

Well structured, the insights they shared with us were very helpful and reliable. Their timely assistance make their services invaluable to us. I would highly recommend them and would definitely use them again in the future if needed...

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements....

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ...



Ken Research, Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

sales [@] kenresearch.com